In order to accelerate and expand its product portfolio, Grifols, S.A. has completed the acquisition of 100% of the stock capital of Tiancheng Pharmaceutical Holdings AG.
A new product line for advanced surgery has been added to the Baxter International, Inc. portfolio with the acquisition of the PerClot Polysaccharide Hemostatic System.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?